TD Cowen raised the firm’s price target on McKesson (MCK) to $864 from $830 and keeps a Buy rating on the shares. The firm updated its model following its investor day where the company raised its long-term adjusted EPS guide and setting the combined long-term NA Pharma and Onc/multispecialty AOI guide higher than previous US Pharma guide.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: